FDA approves first drug for severe itching in chronic kidney disease patients August 24, 2021 Auto Bot BioPharma, biopharma nl, chronic kidney disease, Clinical Trials, Connecticut, FDA, Legal, Pharma 0 Chronic kidney disease patients who experience pruritus after dialysis can now get relief from the first FDA-approved treatment for the condition. Cara Therapeutics received the FDA’s nod green light for its injectable drug, Korsuva.